Arvinas Patents – Key Insights and Stats

Arvinas has a total of 500 patents globally, out of which 355 have been granted. Of these 500 patents, more than 80% patents are active. United States of America is where Arvinas has filed the maximum number of patents, followed by Australia and Europe. Parallelly, United States of America seems to be the main focused R&D centre of Arvinas.

Arvinas was founded in the year 2013 by Craig M. Crews and Lewis B. Cullman. The company focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, and autoimmune.

Do read about some of the most popular patents of Arvinas which have been covered by us in this article and also you can find Arvinas patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Arvinas patent portfolio.

How many patents does Arvinas have?

Arvinas has a total of 500 patents globally. These patents belong to 62 unique patent families. Out of 500 patents, 404 patents are active.

How Many Patents did Arvinas File Every Year?

Arvinas Patent Filling Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantArvinas Applications FiledArvinas Patents Granted
2023– 20
202241140
202174132
20208963
201986– 
201849 –
201785 –
201661 –
201515 –

How many Arvinas patents are Alive/Dead?

Arvinas Patent Portfolio

How Many Patents did Arvinas File in Different Countries?

Arvinas Worldwide Patent Filling

Countries in which Arvinas File Patents

CountriesPatents
United States Of America74
Australia46
Europe37
Korea (South)33
Mexico30
Japan29
China26
Canada26
Israel25
India22
Hong Kong (S.A.R.)21
Brazil19
Russia17
Colombia14
New Zealand6
South Africa4
Taiwan3
Indonesia3
Peru2
Hungary1
Africa1
Costa Rica1
Argentina1
Ecuador1
Malaysia1
Singapore1
Germany1
Spain1
Chile1
Dominican Republic1
Viet Nam1
Italy1
Philippines1

Where are Research Centres of Arvinas Patents Located?

Research Centres of Arvinas Patents

10 Best Arvinas Patents

US20150291562A1 is the most popular patent in the Arvinas portfolio. It has received 289 citations so far from companies like Fl Therapeutics, Celgene Corporation and Kymera Therapeutics.

Below is the list of 10 most cited patents of Arvinas:

Publication NumberCitation Count
US20150291562A1289
US20160058872A1249
US20170008904A1131
WO2017030814A1126
WO2016149668A1122
WO2017011590A1112
WO2016118666A1108
WO2016197032A1104
US20170037004A198
WO2016197114A191

What are Arvinas key innovation segments?

What Technologies are Covered by Arvinas?

The chart below distributes patents filed by Arvinas in different countries on the basis of the technology protected in patents. It also represents the markets where Arvinas thinks it’s important to protect particular technology inventions.

R&D Focus: How has Arvinas search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Arvinas?

Table of Content

Insights you may find interesting

Related Articles

Garena Patents – Insights & Stats (Updated 2024)

Garena has a total of 96 patents globally, out of which 15 have been granted. Of these 96 patents, more than 80% patents are active. Singapore is where Garena has filed the maximum number of patents, followed by United States of America and China. Parallelly, Singapore seems to be the

Read More »

Flexxon Patents – Insights & Stats (Updated 2024)

Flexxon has a total of 68 patents globally, out of which 39 have been granted. Of these 68 patents, more than 89% patents are active. Singapore is where Flexxon has filed the maximum number of patents, followed by United States of America and Australia. Parallelly, Singaporeseems to be the main

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.